{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:21:09Z","timestamp":1792452069178,"version":"4.5.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.clinthera.2004.12.011","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T12:26:37Z","timestamp":1110543997000},"page":"1976-1993","source":"Crossref","is-referenced-by-count":63,"title":["Secondary hyperparathyroidism: Review of the disease and its treatment"],"prefix":"10.1016","volume":"26","author":[{"given":"Angel L.M.","family":"de Francisco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2004.12.011_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000073945","article-title":"Management of secondary hyperparathyroidism: The importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product","volume":"23","author":"Moe","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0272-6386(12)80977-2","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"23","author":"Slatopolsky","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0272-6386(97)90459-5","article-title":"Hyperparathyroidism in the hemodialysis population: A survey of 612 patients","volume":"29","author":"Salem","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/089686080002000308","article-title":"High prevalence of hyperparathyroidism among peritoneal dialysis patients: A review of 176 patients","volume":"20","author":"Billa","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib6","author":"US Renal Data System (USRDS)","year":"2000"},{"key":"10.1016\/j.clinthera.2004.12.011_bib7","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/ndt\/gfg233","article-title":"Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990\u20131999","volume":"18","author":"Stengel","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib8","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1097\/01.ASN.0000100127.54107.57","article-title":"Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"14","author":"Goodkin","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib9","first-page":"239","article-title":"Cardiovascular disease and mortality in ESRD","volume":"11","author":"Foley","year":"1998","journal-title":"J Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ndt\/17.2.336","article-title":"Cardiovascular calcification in end-stage renal disease","volume":"17","author":"Salusky","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"Bone metabolism and disease in chronic kidney disease","volume":"42","author":"Eknoyan","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","article-title":"The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure","volume":"29","author":"Martinez","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00302067","article-title":"Intact parathyroid hormone levels in renal insufficiency","volume":"57","author":"Fajtova","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib15","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.V9101845","article-title":"High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro","volume":"9","author":"Almaden","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib16","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2004.12.011_bib17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ki.1991.314","article-title":"Calcemic response to parathyroid hormone in renal failure: Role of phosphorus and its effect on calcitriol","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ki.1991.315","article-title":"Calcemic response to parathyroid hormone in renal failure: Role of calcitriol and the effect of parathyroidectomy","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1026570518919","article-title":"Calcium receptor and regulation of parathyroid hormone secretion","volume":"1","author":"Brown","year":"2000","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.clinthera.2004.12.011_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib21","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1523-1755.2002.kid585.x","article-title":"Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyper-parathyroidism","volume":"62","author":"Tokumoto","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib22","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2004.12.011_bib23","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1046\/j.1523-1755.61.s80.26.x","article-title":"Pathogenesis of refractory secondary hyperparathyroidism","volume":"61","author":"Rodriguez","year":"2002","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clinthera.2004.12.011_bib24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0002-9343(78)90748-9","article-title":"Central nervous system manifestations of hyperparathyroidism","volume":"65","author":"Cogan","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2004.12.011_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1309\/AGLF-X21H-Y37W-50KL","article-title":"Cutaneous calciphylaxis. An underrecognized clinicopathologic entity","volume":"113","author":"Essary","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ki.1980.114","article-title":"Pulmonary calcification in hemodialyzed patients detected by technetium-99m diphosphonate scanning","volume":"18","author":"Faubert","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ki.1991.186","article-title":"Inhibition of immunoglobulin production by parathyroid hormone. Implications in chronic renal failure","volume":"40","author":"Gaciong","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib28","first-page":"739","article-title":"Effect of secondary hyperparathyroidism on the anaemia of end-stage renal failure: In vivo and in vitro studies","volume":"20","author":"Grutzmacher","year":"1983"},{"key":"10.1016\/j.clinthera.2004.12.011_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/jcem-60-2-229","article-title":"The influence of hyperparathyroidism on glucose metabolism in uremia","volume":"60","author":"Mak","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2004.12.011_bib30","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1359\/jbmr.2002.17.12.2094","article-title":"Pathophysiology and recent advances in the management of renal osteodystrophy","volume":"17","author":"Elder","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2004.12.011_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0272-6386(95)90599-5","article-title":"Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis","volume":"26","author":"Qi","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000057611","article-title":"Renal osteodystrophy in predialysis and hemodialysis patients: Comparison of histologic patterns and diagnostic predictivity of intact PTH","volume":"91","author":"Coen","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.clinthera.2004.12.011_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","article-title":"Renal osteodystrophy","volume":"333","author":"Hruska","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2004.12.011_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/jcem-39-1-119","article-title":"Quantitative histological studies on the pathogenesis of uremic bone disease","volume":"39","author":"Sherrad","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2004.12.011_bib35","series-title":"Clinical Disorders of Bone and Mineral Metabolism","first-page":"254","article-title":"Uremic osteodystrophy: Classification, cause, treatment","author":"Sherrard","year":"1983"},{"key":"10.1016\/j.clinthera.2004.12.011_bib36","first-page":"437","article-title":"Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis","volume":"13","author":"Gerakis","year":"2000","journal-title":"J Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib37","series-title":"Oxford Textbook of Medicine","first-page":"278","article-title":"Bone disease in chronic renal failure","author":"Schomig","year":"2003"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2004.12.011_bib38","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1053\/ajkd.2003.50094","article-title":"Vascular calcification in dialysis patients: Pathogenesis and consequences","volume":"41","author":"Reslerova","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/ndt\/gfg116","article-title":"Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis","volume":"18","author":"Spasovski","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib40","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1053\/ajkd.2002.33401","article-title":"Analysis of renal bone disease treatment in dialysis patients","volume":"39","author":"Johnson","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jbmr.5650100121","article-title":"Risk factors for renal osteodystrophy: A multivariant analysis","volume":"10","author":"Pei","year":"1995","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2004.12.011_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ndt\/17.suppl_2.21","article-title":"Aluminium and bone disease in chronic renal failure","volume":"17","author":"Malluche","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2004.12.011_bib43","first-page":"12","article-title":"Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine","volume":"6","author":"Coburn","year":"1986","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib44","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/oxfordjournals.ndt.a027356","article-title":"Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients\u2014retrospective analysis of 1429 iliac crest biopsies","volume":"11","author":"Ballanti","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2004.12.011_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndt\/10.supp3.13","article-title":"Renal osteodystrophy: Pathogenesis and management","volume":"10","author":"Gonzalez","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","article-title":"Risk factors for vertebral fractures in renal osteodystrophy","volume":"33","author":"Atsumi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib47","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib48","series-title":"Abstract presented at the 41st European Renal Association-European Dialysis and Transplant Association Congress","article-title":"Association of elevated serum parathyroid hormone (PTH) and calcium with risk of hip, vertebral or pelvic fracture in hemodialysis patients","author":"Kim","year":"2004"},{"key":"10.1016\/j.clinthera.2004.12.011_bib49","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00041552-200007000-00007","article-title":"Is aplastic osteodystrophy a disease of malnutrition?","volume":"9","author":"Fukagawa","year":"2000","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.clinthera.2004.12.011_bib50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ndt\/15.7.953","article-title":"Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)","volume":"15","author":"Stenvinkel","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib51","series-title":"Kelley's Textbook of Rheumatology","first-page":"525","article-title":"Hip and knee pain","author":"Dillingham","year":"2001"},{"key":"10.1016\/j.clinthera.2004.12.011_bib52","series-title":"Campbell's Operative Orthopaedics","first-page":"2181","article-title":"Fractures of hip, acetabulum, and pelvis","author":"Guyton","year":"1998"},{"key":"10.1016\/j.clinthera.2004.12.011_bib53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1525-139X.2003.160301.x","article-title":"Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease","volume":"16","author":"Block","year":"2003","journal-title":"Semin Dial"},{"key":"10.1016\/j.clinthera.2004.12.011_bib54","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1681\/ASN.V4101814","article-title":"A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia","volume":"4","author":"Amann","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib55","first-page":"2043","article-title":"Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: Evidence for a permissive action of PTH","volume":"10","author":"Amann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1081\/JDI-100001291","article-title":"Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients","volume":"23","author":"Strozecki","year":"2001","journal-title":"Ren Fail"},{"key":"10.1016\/j.clinthera.2004.12.011_bib57","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ndt\/12.5.933","article-title":"Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans","volume":"12","author":"Fliser","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib58","first-page":"72","article-title":"Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients","volume":"21","author":"Hara","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.clinthera.2004.12.011_bib59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib60","doi-asserted-by":"crossref","first-page":"E686","DOI":"10.1152\/ajpendo.00552.2003","article-title":"Osteogenic regulation of vascular calcification: An early perspective","volume":"286","author":"Vattikuti","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2004.12.011_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1525-139X.2003.160271.x","article-title":"Clinical epidemiology of cardiac disease in dialysis patients: Left ventricular hypertrophy, ischemic heart disease, and cardiac failure","volume":"16","author":"Foley","year":"2003","journal-title":"Semin Dial"},{"key":"10.1016\/j.clinthera.2004.12.011_bib62","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ndt\/17.4.645","article-title":"Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients","volume":"17","author":"De Lima","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3346\/jkms.1998.13.5.488","article-title":"Prevalence and patterns of left ventricular hypertrophy in patients with predialysis chronic renal failure","volume":"13","author":"Ha","year":"1998","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clinthera.2004.12.011_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","article-title":"Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide","volume":"37","author":"Schluter","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.clinthera.2004.12.011_bib65","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1046\/j.1523-1755.63.s85.26.x","article-title":"Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population","volume":"85","author":"Marco","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clinthera.2004.12.011_bib66","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca \u00d7 PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2004.12.011_bib67","first-page":"678","article-title":"Predictors and consequences of serum calcium concentration in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"18","author":"Young","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib68","first-page":"A16","article-title":"Relationship between serum calcium and mortality risk in hemodialysis patients","volume":"41","author":"Block","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib69","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib70","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2004.12.011_bib71","first-page":"678","article-title":"Predictors of hyperphosphatemia and its association with cardiovascular deaths and hospitalization in chronic hemodialysis patients: International results from the DOPPS","volume":"18","author":"Pisoni","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib72","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2004.12.011_bib73","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.ASN.0000038685.95946.83","article-title":"Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study","volume":"14","author":"Wang","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib75","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/ndt\/13.8.2037","article-title":"Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism","volume":"13","author":"Ribeiro","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib76","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2004.12.011_bib77","first-page":"A15","article-title":"Elevated PTH and Ca \u00d7 P levels are associated with increased hospitalization in haemodialysis patients","volume":"41","author":"Block","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib78","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1523-1755.2003.00120.x","article-title":"The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis","volume":"64","author":"Grandaliano","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib79","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1053\/ajkd.2003.50000","article-title":"Factors associated with future amputation among patients undergoing hemodialysis: Results from the Dialysis Morbidity and Mortality Study Waves 3 and 4","volume":"41","author":"O'Hare","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib80","first-page":"245A","article-title":"Trends in parathyroidectomy rates in U.S. dialysis patients 1992\u20132001","volume":"14","author":"Foley","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2004.12.011_bib81","first-page":"677","article-title":"Prevalence of values on mineral metabolism being made outside the targets from the proposed new draft NKF-K\/DOQI and European Best Practice Guidelines in countries of the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"18","author":"Young","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib82","first-page":"165","article-title":"Calcium, phosphate, and PTH levels in the hemodialysis population: A multicenter study","volume":"15","author":"Gallieni","year":"2002","journal-title":"J Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib83","first-page":"474A","article-title":"Applying the K\/DOQI guidelines cut-off levels to the dialysis population: How far are we from the target?","volume":"14","author":"Cannata-Andia","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib84","first-page":"473A","article-title":"Patient prevalence within proposed NKF-K\/DOQI guidelines for bone metabolism and disease","volume":"14","author":"Walters","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib85","first-page":"269A","article-title":"Achievement of proposed NKF-K\/DOQI bone metabolism and disease guidelines: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"14","author":"Kim","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib86","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1523-1755.2000.00819.x","article-title":"Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients","volume":"57","author":"Indridason","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib87","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000013490","article-title":"Treatment of secondary hyperparathyroidism in hemodialyzed patients with high-dose calcium carbonate without vitamin D3 supplements","volume":"19","author":"Teruel","year":"1999","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib88","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000441-199906000-00006","article-title":"Medical management of secondary hyperparathyroidism in uremia","volume":"317","author":"Drueke","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clinthera.2004.12.011_bib89","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/ndt\/17.5.723","article-title":"Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia","volume":"17","author":"Locatelli","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib90","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0272-6386(95)90011-X","article-title":"Limitations of pulse oral calcitriol therapy in continuous ambulatory peritoneal dialysis patients","volume":"25","author":"Bechtel","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib91","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000170266","article-title":"High frequency of marked hyperphosphatemia during intravenous calcitriol therapy in hemodialysis patients with refractory hyperparathyroidism","volume":"14","author":"Descombes","year":"1996","journal-title":"Blood Purif"},{"key":"10.1016\/j.clinthera.2004.12.011_bib92","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ndt\/gfg017","article-title":"Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism","volume":"18","author":"Costa","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib93","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ki.1992.404","article-title":"Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients","volume":"42","author":"Gallieni","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib94","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2004.12.011_bib95","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000184946","article-title":"Suppression of serum parathyroid hormone levels by intravenous alphacalcidol in uremic patients on maintenance hemodialysis. A pilot study","volume":"48","author":"Lind","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.clinthera.2004.12.011_bib96","first-page":"315","article-title":"A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease","volume":"56","author":"Lindberg","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib97","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-alpha-25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib98","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib99","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0272-6386(96)90252-8","article-title":"Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism","volume":"28","author":"Malberti","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib100","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/ki.1994.223","article-title":"Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD","volume":"45","author":"Quarles","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib101","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1523-1755.1999.00538.x","article-title":"Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient","volume":"56","author":"Rodriguez","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.12.011_bib102","first-page":"272","article-title":"Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients","volume":"34","author":"Cannella","year":"1990","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib103","first-page":"324","article-title":"Long-term high dose intravenous calcitriol therapy in end-stage renal disease patients with severe secondary hyperparathyroidism","volume":"43","author":"Dressler","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib104","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/ajkd.2000.16193","article-title":"Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism","volume":"36","author":"Frazao","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0272-6386(12)80831-6","article-title":"Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol","volume":"19","author":"Sprague","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib106","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1046\/j.1523-1755.1999.07307.x","article-title":"What is the optimal regimen for vitamin D?","volume":"73","author":"Cunningham","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clinthera.2004.12.011_bib107","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.CIR.98.13.1302","article-title":"1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide","volume":"98","author":"Jono","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2004.12.011_bib108","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0272-6386(01)80010-X","article-title":"Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison","volume":"37","author":"Maung","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib109","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.RES.0000025269.60668.0F","article-title":"1Alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase","volume":"91","author":"Rebsamen","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2004.12.011_bib110","first-page":"111","article-title":"Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients","volume":"45","author":"Janssen","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib111","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0272-6386(99)70221-0","article-title":"A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients","volume":"33","author":"Bleyer","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2004.12.011_bib112","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Guerin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib113","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/ndt\/8.6.530","article-title":"Calcium carbonate (CaCO3): An efficient and safe phosphate binder in haemodialysis patients? A 3-year study","volume":"8","author":"Sperschneider","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib114","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/ndt\/9.8.1121","article-title":"Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis","volume":"9","author":"Pflanz","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2004.12.011_bib115","first-page":"764A","article-title":"Lanthanum carbonate vs. standard therapy in hyperphosphatemia: Interim findings from a 2-year safety and outcomes study","volume":"14","author":"Finn","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib116","first-page":"461A","article-title":"Oral cinacalcet HCl (AMG 073) for the treatment of hemodialysis patients with secondary hyperparathyroidism (HPT): Results of a European\/Australian phase 3 study","volume":"14","author":"de Francisco","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib117","first-page":"463A","article-title":"Long-term treatment of secondary hyperparathyroidism (HPT) with the calcimimetic cinacalcet HCl","volume":"14","author":"Moe","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2004.12.011_bib118","series-title":"Press release regarding approval of cinacalcet","author":"US Food and Drug Administration","year":"2004"},{"key":"10.1016\/j.clinthera.2004.12.011_bib120","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2004.12.011_bib121","first-page":"48A","article-title":"Achievement of proposed NKF-K\/DOQI bone metabolism and disease targets: Treatment with cinacalcet HCl in dialysis patients with uncontrolled secondary hyperparathyroidism (HPT)","volume":"14","author":"Moe","year":"2003","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291804000815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291804000815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T20:30:57Z","timestamp":1625603457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291804000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":120,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0149291804000815"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2004.12.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}